Advances in Pharmaceutical Research (APR) is a publication platform meant for exchanging and sharing current knowledge in pharmaceutical studies.
APR strives to be the top journal for publishing a diverse range of articles, including original research articles, clinical reviews, case studies and reports, and more, covering all aspects of manufacturing, formulating, reviewing, and monitoring. Our goal is to ensure the safe, effective, and affordable use of medications while also fostering the exploration of innovative developments in pharmaceutical studies.
As a comprehensive, peer-reviewed, online, open-access journal that is released once every 2 months, APR serves as a trusted forum for pharmacists, physicians, surgeons, scientists, and other professionals worldwide to foster, share, and discuss the latest developments in pharmaceutical interventions.
Objective:
The journal serves as a center for scientific discourse on advancements in health sciences and pharmaceuticals.
Aim:
Compiling meticulous data for future research in this crucial field.
Scope:
Encompassing studies on pharmaceutical advancements, analytical methods, drug design, medicinal research, biopharmaceutics, pharmaceutical biotechnology, organic chemistry, pharmacology, toxicology, regulatory affairs, pharmacovigilance, drug safety, and discovery.
Time Frame:
Peer review: 15-41 days
Acceptance to publication: 5-10 days
Page proof to final publication: 5-8 days
All submissions undergo double-blind peer review, ensuring trustworthiness and significance. Published articles are immediately accessible for reading and reuse, provided proper credit is given for non-commercial purposes.
The journal follows the principles laid down by the Committee on Publication Ethics (COPE).
Authors can submit manuscripts directly through the submission portal on the website or via email as an attachment to xxxxxxxxxxxxxxxx
All submitted articles undergo a rigorous double-blind peer-review process to ensure credibility and significance.
Open Access Policy:
Aspirant is an open-access journal distributing articles under the Attribution 4.0 International (CC BY 4.0) license. This allows users to read, reuse, and redistribute content, provided appropriate credit is given, and no additional restrictions are imposed.
As a Committee on Publication Ethics (COPE) member, APR adheres to high ethical standards in publishing.
Authors are encouraged to submit manuscripts directly via the submission portal on the website or as attachments via email to xxxxxxxxxxxx
Ahead of Print Policy:
Articles published online under the "online first" category are considered published and can be cited using the DOI or citation provided. No modifications will be made post-publication, but authors can contact the editorial office for necessary changes via email:
Journal Scope: